ACP

Acuta Capital Partners Portfolio holdings

AUM $147M
1-Year Est. Return 491.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+491.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$173M
AUM Growth
-$15M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$7.06M
2
+$6.04M
3
+$4.72M
4
IMMU
Immunomedics Inc
IMMU
+$3.51M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$3.2M

Top Sells

1
+$10.6M
2
+$4.78M
3
+$3.75M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$3.17M
5
TVTX icon
Travere Therapeutics
TVTX
+$2.58M

Sector Composition

1 Healthcare 71.32%
2 Technology 2.19%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$21.1M 12.23%
2,500,000
+997,339
2
$14.8M 8.56%
2,736,642
+1,020,642
3
$13.8M 8%
5,526,172
+1,562,139
4
$12.7M 7.36%
2,500,000
+585,000
5
$11.7M 6.76%
826,799
+349,499
6
$11.6M 6.7%
623,631
+104,388
7
$7.95M 4.6%
608,318
+111,091
8
$7.03M 4.07%
590,530
+213,883
9
$6.72M 3.89%
657,670
+200,670
10
$5.51M 3.19%
+500,000
11
$4.88M 2.83%
2,180
+529
12
$4.62M 2.67%
824,500
+466,153
13
$4.51M 2.61%
1,063,747
+84,840
14
$3.8M 2.2%
2,678,753
+126,950
15
$3.79M 2.19%
70,000
-217,397
16
$3.68M 2.13%
210,000
-40,000
17
$3.52M 2.04%
19,255
+11,315
18
$3.48M 2.02%
+386,308
19
$3.24M 1.88%
377,765
+57,210
20
$3.05M 1.77%
308,044
+117,944
21
$2.73M 1.58%
200,000
-170,000
22
$2.21M 1.28%
103,283
+14,844
23
$1.71M 0.99%
64,955
24
$1.62M 0.94%
77,684
+32,078
25
$1.52M 0.88%
23,367
+7,242
1
2 3